CanSino Biologics (Germany) Market Value
| CJH Stock | 3.66 0.12 3.17% |
| Symbol | CanSino |
CanSino Biologics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CanSino Biologics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CanSino Biologics.
| 02/04/2023 |
| 12/25/2024 |
If you would invest 0.00 in CanSino Biologics on February 4, 2023 and sell it all today you would earn a total of 0.00 from holding CanSino Biologics or generate 0.0% return on investment in CanSino Biologics over 690 days. CanSino Biologics is related to or competes with Merck KGaA, Haleon PLC, LIVZON PHARMAC, SIMCERE PHARMAC, Evotec SE, and Dermapharm Holding. More
CanSino Biologics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CanSino Biologics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CanSino Biologics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.7 | |||
| Information Ratio | 0.1355 | |||
| Maximum Drawdown | 30.83 | |||
| Value At Risk | (5.82) | |||
| Potential Upside | 13.07 |
CanSino Biologics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CanSino Biologics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CanSino Biologics' standard deviation. In reality, there are many statistical measures that can use CanSino Biologics historical prices to predict the future CanSino Biologics' volatility.| Risk Adjusted Performance | 0.1236 | |||
| Jensen Alpha | 0.7337 | |||
| Total Risk Alpha | 0.5237 | |||
| Sortino Ratio | 0.1532 | |||
| Treynor Ratio | 1.27 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of CanSino Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
CanSino Biologics Backtested Returns
CanSino Biologics appears to be very risky, given 3 months investment horizon. CanSino Biologics secures Sharpe Ratio (or Efficiency) of 0.14, which signifies that the company had a 0.14% return per unit of risk over the last 3 months. By analyzing CanSino Biologics' technical indicators, you can evaluate if the expected return of 0.74% is justified by implied risk. Please makes use of CanSino Biologics' Downside Deviation of 4.7, risk adjusted performance of 0.1236, and Mean Deviation of 3.59 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, CanSino Biologics holds a performance score of 10. The firm shows a Beta (market volatility) of 0.59, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CanSino Biologics' returns are expected to increase less than the market. However, during the bear market, the loss of holding CanSino Biologics is expected to be smaller as well. Please check CanSino Biologics' downside variance, rate of daily change, and the relationship between the maximum drawdown and skewness , to make a quick decision on whether CanSino Biologics' price patterns will revert.
Auto-correlation | -0.49 |
Modest reverse predictability
CanSino Biologics has modest reverse predictability. Overlapping area represents the amount of predictability between CanSino Biologics time series from 4th of February 2023 to 15th of January 2024 and 15th of January 2024 to 25th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CanSino Biologics price movement. The serial correlation of -0.49 indicates that about 49.0% of current CanSino Biologics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.49 | |
| Spearman Rank Test | -0.66 | |
| Residual Average | 0.0 | |
| Price Variance | 0.34 |
CanSino Biologics lagged returns against current returns
Autocorrelation, which is CanSino Biologics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting CanSino Biologics' stock expected returns. We can calculate the autocorrelation of CanSino Biologics returns to help us make a trade decision. For example, suppose you find that CanSino Biologics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
CanSino Biologics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If CanSino Biologics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if CanSino Biologics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in CanSino Biologics stock over time.
Current vs Lagged Prices |
| Timeline |
CanSino Biologics Lagged Returns
When evaluating CanSino Biologics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of CanSino Biologics stock have on its future price. CanSino Biologics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, CanSino Biologics autocorrelation shows the relationship between CanSino Biologics stock current value and its past values and can show if there is a momentum factor associated with investing in CanSino Biologics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for CanSino Stock Analysis
When running CanSino Biologics' price analysis, check to measure CanSino Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CanSino Biologics is operating at the current time. Most of CanSino Biologics' value examination focuses on studying past and present price action to predict the probability of CanSino Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CanSino Biologics' price. Additionally, you may evaluate how the addition of CanSino Biologics to your portfolios can decrease your overall portfolio volatility.